Cytotoxicity of Pyrazine-Based Cyclometalated (C∧NPZ∧C)Au(III) Carbene Complexes: Impact of the Nature of the Ancillary Ligand on the Biological Properties

被引:58
作者
Bertrand, Benoit [1 ]
Fernandez-Cestau, Julio [1 ]
Angulo, Jesus [2 ]
Cominetti, Marco M. D. [2 ]
Waller, Zoe A. E. [2 ]
Searcey, Mark [1 ,2 ]
O'Connell, Maria A. [2 ]
Bochmann, Manfred [1 ]
机构
[1] Univ East Anglia, Sch Chem, Norwich NR4 7TJ, Norfolk, England
[2] Univ East Anglia, Sch Pharm, Norwich NR4 7TJ, Norfolk, England
基金
欧洲研究理事会;
关键词
DNA G-QUADRUPLEX; I-MOTIF; GOLD(III) COMPLEXES; THIOREDOXIN REDUCTASE; METAL-COMPLEXES; GENE PROMOTERS; TELOMERIC DNA; BASIS-SETS; ANTICANCER; AGENTS;
D O I
10.1021/acs.inorgchem.7b00339
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
The synthesis of a series of cyclometalated gold(III) complexes supported by pyrazitie-based ((CNC)-N-boolean AND-C-boolean AND)-type pincer ligands is reported, including the crystal structure of a cationic example. The compounds provide a new platform for the study of antiproliferative properties of gold(III) complexes. Seven complexes were tested: the neutral series ((CNC)-N-boolean AND-C-PZ boolean AND)AuX [X = Cl (1), 6-thioguanine (4), C equivalent to CPh (5), SPh (6)] and an ionic series that included the N-methyl complex [((CNC)-N-boolean AND-C-pzMe boolean AND)AUCl]BF4 (7) and the N-heterocyclic carbene complexes [((CNC)-N-boolean AND-C-pz boolean AND)AuL](+) with L = 1,3-dimethylbenzimidazol-2-ylidene (2) or 1,3,7,9-tetramethylxanthin.-8-ylidene (3). Tests against human leukemia, tells identified 1, 2, 3, and 4 as particularly promising, whereas protecting the nonCoordinated N atom on the pyrazine ring by methylation (as in 7) -reduced the cytotoxicity. Complex 2 proved to be the most effective of the entire series against the HL60, leukemia, MCF-7 breast cancer, and A549 lung cancer cell lines, with IC50 values down to submicromolar levels, associated, with a lower toxicity, toward healthy human lung fibroblast cells. The benzimidazolylidene complex 2 accumulated more effectively in human lung,,canter,cells than its caffeine-based analogue 3 and the gold(III) chloride 1. Compound 2 proved to be unaffected by ghitathione under physiological conditions for periods of up to 6 days and stabilizes the DNA G-quadruplex and 1 motif structures; the latter is the first such report for gold compounds. We also, show the first evidence of inhibition of MDM2 p53 protein-protein interactions by a gold-based compound and identified the binding mode of the compound with MDM2 using saturation transfer difference NMR spectroscopy combined with docking calculations.
引用
收藏
页码:5728 / 5740
页数:13
相关论文
共 97 条
[1]   Unveiling the "Three-Finger Pharmacophore" Required for p53-MDM2 Inhibition by Saturation-Transfer Difference (STD) NMR Initial Growth-Rates Approach [J].
Angulo, Jesus ;
Goffin, Sarah A. ;
Gandhi, Daivik ;
Searcey, Mark ;
Howell, Lesley A. .
CHEMISTRY-A EUROPEAN JOURNAL, 2016, 22 (17) :5858-5862
[2]  
[Anonymous], 2010, CrysAlisPro
[3]  
[Anonymous], 1992, INTERNATIONAL TABLES, VC, p[500, 219, 193]
[4]   Luminescent Cyclometalated N-Heterocyclic Carbene-Containing Organogold(III) Complexes: Synthesis, Characterization, Electrochemistry, and Photophysical Studies [J].
Au, Vonika Ka-Man ;
Wong, Keith Man-Chung ;
Zhu, Nianyong ;
Yam, Vivian Wing-Wah .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2009, 131 (25) :9076-9085
[5]   Targeting G-quadruplexes in gene promoters: a novel anticancer strategy? [J].
Balasubramanian, Shankar ;
Hurley, Laurence H. ;
Neidle, Stephen .
NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (04) :261-275
[6]   Determinants for Tight and Selective Binding of a Medicinal Dicarbene Gold(I) Complex to a Telomeric DNA G-Quadruplex: a Joint ESI MS and XRD Investigation [J].
Bazzicalupi, Carla ;
Ferraroni, Marta ;
Papi, Francesco ;
Massai, Lara ;
Bertrand, Benoit ;
Messori, Luigi ;
Gratteri, Paola ;
Casini, Angela .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2016, 55 (13) :4256-4259
[7]   Gold compounds as therapeutic agents for human diseases [J].
Berners-Price, Susan J. ;
Filipovska, Aleksandra .
METALLOMICS, 2011, 3 (09) :863-873
[8]   Exploring the potential of gold(III) cyclometallated compounds as cytotoxic agents: variations on the C∧N theme [J].
Bertrand, B. ;
Spreckelmeyer, S. ;
Bodio, E. ;
Cocco, F. ;
Picquet, M. ;
Richard, P. ;
Le Gendre, P. ;
Orvig, C. ;
Cinellu, M. A. ;
Casini, A. .
DALTON TRANSACTIONS, 2015, 44 (26) :11911-11918
[9]   Development of trackable metal-based drugs: new generation of therapeutic agents [J].
Bertrand, Benoit ;
Doulain, Pierre-Emmanuel ;
Goze, Christine ;
Bodio, Ewen .
DALTON TRANSACTIONS, 2016, 45 (33) :13005-13011
[10]   A golden future in medicinal inorganic chemistry: the promise of anticancer gold organometallic compounds [J].
Bertrand, Benoit ;
Casini, Angela .
DALTON TRANSACTIONS, 2014, 43 (11) :4209-4219